ASTRAZENECA LP et al v. HEC PHARM CO., LTD. et al > Summary
Court Case Number 2:19-cv-14737
Filing Date Jul 3, 2019
Termination Date Jan 13, 2020
Court New Jersey District Court
Status Dismissed - Settled
JudgesClaire C. Cecchi, Mark Falk
Defendant
Plaintiff Attorneys
7ASTRAZENECA LP
Attorney Name: John E. Flaherty
McCarter & English
AstraZeneca
Attorney Name: John E. Flaherty
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Mark J. Feldstein
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Jill Kirsten Macalpine
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ravin R. Patel
McCarter & English
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
RE046276 | Triazolo(4,5-D)pyrimidine compounds | Jan 17, 2017 |
07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
06525060 | Triazolo(4,5-d)pyrimidine compounds | Feb 25, 2003 |